Gelderblom, H.

patient group grade model hypertension cancer clearance study pharmacokinetic docetaxel smoking sunitinib imatinib treatment analysis lf abnormalities liver survival abnormality population effect grade 3 hypertension docetaxel clearance polymorphism function ermbt cyp 1a smoker parameter blood variability cycle value sunitinib treatment therapy concentration covariate number table pressure association factor toxicity plasma article outcome nonsmokers cyp 3a activity haplotype change center result erythromycin breath test tumor baseline figure cyp 3a department toxicitie vegfa netherland volume diastolic blood pressure treatment cycle oncol acg haplotype binding model blood pressure liver function university exposure disease systolic blood pressure research multivariate group 3 b progression vegfr stromal phosphatase